TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

HedgePath Pharmaceuticals Inc (OTCMKTS:HPPI) Investor Investigation Announced

  • If you purchased shares of HedgePath Pharmaceuticals Inc (OTCMKTS:HPPI) and currently hold any of those OTCMKTS:HPPI shares, you have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
HedgePath Pharmaceuticals Inc
Security
OTCMKTS: HPPI

Summary

April 7, 2017 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of HedgePath Pharmaceuticals Inc (OTCMKTS:HPPI) was announced over potential breaches of fiduciary duties by certain officers and directors at HedgePath Pharmaceuticals Inc.

The investigation by a law firm concerns whether certain HedgePath Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.

Tampa, FL based HedgePath Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical that is focused on discovering, developing and commercializing therapeutics for patients with certain cancers.

Shares of HedgePath Pharmaceuticals Inc (OTCMKTS:HPPI) declined from $0.47 per share in August 2016 to as low as $0.24 per share on March 22, 2017.

Start Monitoring Your Investments